Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program

Marco Pahor, Ronald I. Shorr, Grant W. Somes, William C. Cushmam, Luiei Ferrucci, James Bailey, Janet T. Elam, William B. Applegate

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Background: It is expected that the treatment of hypertension in patients with renal disease decreases the risk of cardiovascular events, but the evidence in these patients is lacking. Objective: To assess the effect of diuretic-based treatment on cardiovascular events in patients with isolated systolic hypertension and renal dysfunction. Methods: A total of 4336 persons aged 60 years and older with systolic blood pressures of 160 mm Hg and higher and diastolic blood pressures of less than 90 mm Hg were randomly assigned to receive either placebo or chlorthalidone (12.5-25.0 mg/d), with the addition of atenolol (25-50 mg/d) or reserpine (0.050.10 mg/d) if needed, and observed for 5 years. The risk of first-occurring cardiovascular events, including stroke, transient ischemic attack, myocardial infarction, heart failure, coronary artery bypass surgery, angioplasty, aneurysm, endarterectomy, sudden death, or rapid death, was stratified according to baseline serum creatinine levels (35.4-84.0, 84.1-101.6, 101.7-119.3, and 119.4-212.2 μmol/L [0.4- 0.9, 1.0-1.1, 1.2-1.3, and 1.4-2.4 mg/dL]). Results: Systolic blood pressure reduction was not affected by baseline serum creatinine levels. Active treatment did not affect the risk of serum creatinine levels becoming elevated during follow-up. The risk of hypokalemia with active treatment decreased significantly with increasing baseline serum creatinine levels. In the 4 baseline serum creatinine groups, the relative risk (95% confidence interval) of cardiovascular events developing with active treatment was 0.73 (0.54-0.97), 0.63 (0.49-0.82), 0.62 (0.44-0.87), and 0.59 (0.38-0.91). The results were similar for the outcomes of stroke or coronary artery events and in analyses stratified by sex or age. Conclusion: Diuretic-based treatment of patients with isolated systolic hypertension prevents the development of cardiovascular events in older persons with mild renal dysfunction.

Original languageEnglish (US)
Pages (from-to)1340-1345
Number of pages6
JournalArchives of Internal Medicine
Volume158
Issue number12
DOIs
StatePublished - Jul 2 1998

Fingerprint

Diuretics
Creatinine
Hypertension
Kidney
Blood Pressure
Serum
Therapeutics
Stroke
Chlorthalidone
Endarterectomy
Renal Hypertension
Atenolol
Hypokalemia
Reserpine
Transient Ischemic Attack
Sudden Death
Angioplasty
Coronary Artery Bypass
Aneurysm
Coronary Vessels

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program. / Pahor, Marco; Shorr, Ronald I.; Somes, Grant W.; Cushmam, William C.; Ferrucci, Luiei; Bailey, James; Elam, Janet T.; Applegate, William B.

In: Archives of Internal Medicine, Vol. 158, No. 12, 02.07.1998, p. 1340-1345.

Research output: Contribution to journalArticle

Pahor, Marco ; Shorr, Ronald I. ; Somes, Grant W. ; Cushmam, William C. ; Ferrucci, Luiei ; Bailey, James ; Elam, Janet T. ; Applegate, William B. / Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program. In: Archives of Internal Medicine. 1998 ; Vol. 158, No. 12. pp. 1340-1345.
@article{4372438ce1b44fcdab82158d814d56f7,
title = "Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program",
abstract = "Background: It is expected that the treatment of hypertension in patients with renal disease decreases the risk of cardiovascular events, but the evidence in these patients is lacking. Objective: To assess the effect of diuretic-based treatment on cardiovascular events in patients with isolated systolic hypertension and renal dysfunction. Methods: A total of 4336 persons aged 60 years and older with systolic blood pressures of 160 mm Hg and higher and diastolic blood pressures of less than 90 mm Hg were randomly assigned to receive either placebo or chlorthalidone (12.5-25.0 mg/d), with the addition of atenolol (25-50 mg/d) or reserpine (0.050.10 mg/d) if needed, and observed for 5 years. The risk of first-occurring cardiovascular events, including stroke, transient ischemic attack, myocardial infarction, heart failure, coronary artery bypass surgery, angioplasty, aneurysm, endarterectomy, sudden death, or rapid death, was stratified according to baseline serum creatinine levels (35.4-84.0, 84.1-101.6, 101.7-119.3, and 119.4-212.2 μmol/L [0.4- 0.9, 1.0-1.1, 1.2-1.3, and 1.4-2.4 mg/dL]). Results: Systolic blood pressure reduction was not affected by baseline serum creatinine levels. Active treatment did not affect the risk of serum creatinine levels becoming elevated during follow-up. The risk of hypokalemia with active treatment decreased significantly with increasing baseline serum creatinine levels. In the 4 baseline serum creatinine groups, the relative risk (95{\%} confidence interval) of cardiovascular events developing with active treatment was 0.73 (0.54-0.97), 0.63 (0.49-0.82), 0.62 (0.44-0.87), and 0.59 (0.38-0.91). The results were similar for the outcomes of stroke or coronary artery events and in analyses stratified by sex or age. Conclusion: Diuretic-based treatment of patients with isolated systolic hypertension prevents the development of cardiovascular events in older persons with mild renal dysfunction.",
author = "Marco Pahor and Shorr, {Ronald I.} and Somes, {Grant W.} and Cushmam, {William C.} and Luiei Ferrucci and James Bailey and Elam, {Janet T.} and Applegate, {William B.}",
year = "1998",
month = "7",
day = "2",
doi = "10.1001/archinte.158.12.1340",
language = "English (US)",
volume = "158",
pages = "1340--1345",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "12",

}

TY - JOUR

T1 - Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program

AU - Pahor, Marco

AU - Shorr, Ronald I.

AU - Somes, Grant W.

AU - Cushmam, William C.

AU - Ferrucci, Luiei

AU - Bailey, James

AU - Elam, Janet T.

AU - Applegate, William B.

PY - 1998/7/2

Y1 - 1998/7/2

N2 - Background: It is expected that the treatment of hypertension in patients with renal disease decreases the risk of cardiovascular events, but the evidence in these patients is lacking. Objective: To assess the effect of diuretic-based treatment on cardiovascular events in patients with isolated systolic hypertension and renal dysfunction. Methods: A total of 4336 persons aged 60 years and older with systolic blood pressures of 160 mm Hg and higher and diastolic blood pressures of less than 90 mm Hg were randomly assigned to receive either placebo or chlorthalidone (12.5-25.0 mg/d), with the addition of atenolol (25-50 mg/d) or reserpine (0.050.10 mg/d) if needed, and observed for 5 years. The risk of first-occurring cardiovascular events, including stroke, transient ischemic attack, myocardial infarction, heart failure, coronary artery bypass surgery, angioplasty, aneurysm, endarterectomy, sudden death, or rapid death, was stratified according to baseline serum creatinine levels (35.4-84.0, 84.1-101.6, 101.7-119.3, and 119.4-212.2 μmol/L [0.4- 0.9, 1.0-1.1, 1.2-1.3, and 1.4-2.4 mg/dL]). Results: Systolic blood pressure reduction was not affected by baseline serum creatinine levels. Active treatment did not affect the risk of serum creatinine levels becoming elevated during follow-up. The risk of hypokalemia with active treatment decreased significantly with increasing baseline serum creatinine levels. In the 4 baseline serum creatinine groups, the relative risk (95% confidence interval) of cardiovascular events developing with active treatment was 0.73 (0.54-0.97), 0.63 (0.49-0.82), 0.62 (0.44-0.87), and 0.59 (0.38-0.91). The results were similar for the outcomes of stroke or coronary artery events and in analyses stratified by sex or age. Conclusion: Diuretic-based treatment of patients with isolated systolic hypertension prevents the development of cardiovascular events in older persons with mild renal dysfunction.

AB - Background: It is expected that the treatment of hypertension in patients with renal disease decreases the risk of cardiovascular events, but the evidence in these patients is lacking. Objective: To assess the effect of diuretic-based treatment on cardiovascular events in patients with isolated systolic hypertension and renal dysfunction. Methods: A total of 4336 persons aged 60 years and older with systolic blood pressures of 160 mm Hg and higher and diastolic blood pressures of less than 90 mm Hg were randomly assigned to receive either placebo or chlorthalidone (12.5-25.0 mg/d), with the addition of atenolol (25-50 mg/d) or reserpine (0.050.10 mg/d) if needed, and observed for 5 years. The risk of first-occurring cardiovascular events, including stroke, transient ischemic attack, myocardial infarction, heart failure, coronary artery bypass surgery, angioplasty, aneurysm, endarterectomy, sudden death, or rapid death, was stratified according to baseline serum creatinine levels (35.4-84.0, 84.1-101.6, 101.7-119.3, and 119.4-212.2 μmol/L [0.4- 0.9, 1.0-1.1, 1.2-1.3, and 1.4-2.4 mg/dL]). Results: Systolic blood pressure reduction was not affected by baseline serum creatinine levels. Active treatment did not affect the risk of serum creatinine levels becoming elevated during follow-up. The risk of hypokalemia with active treatment decreased significantly with increasing baseline serum creatinine levels. In the 4 baseline serum creatinine groups, the relative risk (95% confidence interval) of cardiovascular events developing with active treatment was 0.73 (0.54-0.97), 0.63 (0.49-0.82), 0.62 (0.44-0.87), and 0.59 (0.38-0.91). The results were similar for the outcomes of stroke or coronary artery events and in analyses stratified by sex or age. Conclusion: Diuretic-based treatment of patients with isolated systolic hypertension prevents the development of cardiovascular events in older persons with mild renal dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=0031861208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031861208&partnerID=8YFLogxK

U2 - 10.1001/archinte.158.12.1340

DO - 10.1001/archinte.158.12.1340

M3 - Article

VL - 158

SP - 1340

EP - 1345

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 12

ER -